The growing concern over vitamin D deficiency has boosted sales at Immunodiagnostic Systems, the maker of diagnostic kits, as it increased its dividend by 10 per cent and launched a new automatic diagnostic device.

"Vitamin D is a remarkable market at the moment and has been for the last couple of years," said Roger Duggan, chief executive of IDS.